{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:04:35Z","timestamp":1781622275299,"version":"3.54.5"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["01(3073)\/21\/EMR-II"],"award-info":[{"award-number":["01(3073)\/21\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jinorgbio.2022.111852","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T11:36:18Z","timestamp":1652182578000},"page":"111852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Evaluation of DNA\/BSA interaction and in vitro cell cytotoxicity of \u03bc2-oxido bridged divanadium(V) complexes containing ONO donor ligands"],"prefix":"10.1016","volume":"233","author":[{"given":"Sushree Aradhana","family":"Patra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanu","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurunath","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalisa","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmar","family":"G\u00f6rls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Plass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupam","family":"Dinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2022.111852_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.chemrev.8b00211","article-title":"Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433","volume":"119","author":"Monro","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2165\/00003495-200060040-00005","article-title":"Oxaliplatin","volume":"60","author":"Culy","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0020","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1039\/b917753a","article-title":"Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine","author":"Farrer","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classification of metal-based drugs according to their mechanisms of action","volume":"6","author":"Boros","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/anie.201905171","article-title":"New designs for phototherapeutic transition metal complexes","volume":"59","author":"Imberti","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0035","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1021\/acs.jmedchem.0c00431","article-title":"Ruthenium (II) complex containing a redox-active semiquinonate ligand as a potential chemotherapeutic agent: from synthesis to in vivo studies","volume":"63","author":"Notaro","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0040","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/cr980420v","article-title":"Current status of platinum-based antitumor drugs","volume":"99","author":"Wong","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0305-7372(79)80057-2","article-title":"Cisplatin (cis-diamminedichloroplatinum II)","volume":"6","author":"Prestayko","year":"1979","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0050","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.ccr.2009.01.028","article-title":"Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA","volume":"253","author":"Arnesano","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0055","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1039\/b904071d","article-title":"Recent developments in ruthenium anticancer drugs","volume":"1","author":"Levina","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0065","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1039\/C6MT00002A","article-title":"Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride","volume":"8","author":"Sanna","year":"2016","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0075","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4155\/fmc.12.103","article-title":"The potentiality of vanadium in medicinal applications","volume":"4","author":"Rehder","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0080","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.2174\/092986710793213742","article-title":"Transport of therapeutic vanadium and ruthenium complexes by blood plasma components","volume":"17","author":"Costa Pessoa","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0085","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ejmech.2008.01.002","article-title":"New diketone based vanadium complexes as insulin mimetics","volume":"43","author":"Sheela","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2017.04.053","article-title":"Self-recognition of the racemic ligand in the formation of homochiral dinuclear V (V) complex: in vitro anticancer activity, DNA and HSA interaction","volume":"135","author":"Kazemi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0095","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/cr020607t","article-title":"The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds","volume":"104","author":"Crans","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0100","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.ccr.2010.12.028","article-title":"Potentiality of vanadium compounds as anti-parasitic agents","volume":"255","author":"Gambino","year":"2011","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ccr.2014.12.002","article-title":"Vanadium compounds in medicine","volume":"301","author":"Pessoa","year":"2015","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/acs.jmedchem.8b01330","article-title":"Role of ligands in the uptake and reduction of V (V) complexes in red blood cells","volume":"62","author":"Sanna","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0115","doi-asserted-by":"crossref","first-page":"8950","DOI":"10.1039\/C7DT00943G","article-title":"Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug","volume":"46","author":"Sanna","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0120","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/asia.201700463","article-title":"Stabilities and biological activities of vanadium drugs: what is the nature of the active species?","volume":"12","author":"Levina","year":"2017","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0125","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1073\/pnas.1018603108","article-title":"Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells","volume":"108","author":"Benitez","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/S0085-56262009000100010","article-title":"A new genus and species of gall midge (Diptera, Cecidomyiidae) associated with Myrcia retorta (Myrtaceae)","volume":"53","author":"Maia","year":"2009","journal-title":"Rev. Bras. Entomol."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0135","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm00086a020","article-title":"Bis (maltolato) oxovanadium (IV) is a potent insulin mimic","volume":"35","author":"McNeill","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0140","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1021\/ja00156a013","article-title":"Reaction chemistry of BMOV, bis (maltolato) oxovanadium (IV), a potent insulin mimetic agent","volume":"117","author":"Orvig","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jinorgbio.2008.12.003","article-title":"Vanadium treatment of type 2 diabetes: a view to the future","volume":"103","author":"Thompson","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0150","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.2174\/092986710793213805","article-title":"Potential use of vanadium compounds in therapeutics","volume":"17","author":"Barrio","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccr.2015.03.010","article-title":"The chemistry and biology of vanadium compounds in cancer therapeutics","volume":"301","author":"Kioseoglou","year":"2015","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jinorgbio.2016.11.010","article-title":"Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium (IV) complexes of salicylaldimines and polypyridyl ligands","volume":"166","author":"Scalese","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/187152009789124646","article-title":"Titanium and vanadium complexes as anticancer agents","volume":"9","author":"Kostova","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0170","first-page":"154","article-title":"Studies on the antineoplastic effect of vanadium salts","volume":"343","author":"Kieler","year":"1965","journal-title":"Acta Chir. Scand. Suppl."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0175","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/cr00081a012","article-title":"Non-platinum group metal antitumor agents. History, current status, and perspectives","volume":"87","author":"Koepf-Maier","year":"1987","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0180","first-page":"2124","article-title":"In vivo antitumor activity of bis (4, 7-dimethyl-1, 10-phenanthroline) sulfatooxovanadium (IV){METVAN [VO (SO4)(Me2-Phen) 2]}","volume":"7","author":"Narla","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0185","first-page":"1094","article-title":"Bis (4, 7-dimethyl-1, 10-phenanthroline) sulfatooxovanadium (IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity","volume":"7","author":"Narla","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0190","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1016\/j.ejmech.2011.08.020","article-title":"Influence of chirality of V (V) Schiff base complexes on DNA, BSA binding and cleavage activity","volume":"46","author":"Noor-ul","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0195","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1517\/13543784.11.12.1829","article-title":"Metvan: a novel oxovanadium (IV) complex with broad spectrum anticancer activity","volume":"11","author":"D\u2019Cruz","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2017.01.002","article-title":"Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities","volume":"352","author":"Levina","year":"2017","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0205","doi-asserted-by":"crossref","first-page":"111350","DOI":"10.1016\/j.jinorgbio.2020.111350","article-title":"Therapeutic potential of vanadium complexes with 1, 10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells","volume":"217","author":"Nunes","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/inorganics9020017","article-title":"Misinterpretations in evaluating interactions of vanadium complexes with proteins and other biological targets","volume":"9","author":"Pessoa","year":"2021","journal-title":"Inorganics"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0215","doi-asserted-by":"crossref","first-page":"111582","DOI":"10.1016\/j.jinorgbio.2021.111582","article-title":"Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium (V) salan complexes: exploring the solution behavior of monoalkoxido-bound oxido-vanadium (V) complex","volume":"224","author":"Patra","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0220","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0225","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0968-0896(03)00499-1","article-title":"Artemisinin derivatives bearing Mannich base group: synthesis and antimalarial activity","volume":"11","author":"Li","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0230","first-page":"175","article-title":"Increased potency of vanadium using organic ligands","author":"McNeill","year":"1995","journal-title":"Vanadium Compd."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2004.09.003","article-title":"Synthesis of Schiff bases of 4-(4-aminophenyl)-morpholine as potential antimicrobial agents","volume":"40","author":"Panneerselvam","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2010.05.004","article-title":"Schiff bases: a short review of their antimicrobial activities","volume":"2","author":"Da Silva","year":"2011","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bmcl.2014.11.088","article-title":"Synthesis, analgesic, anti-inflammatory and anti-ulcerogenic activities of certain novel Schiff\u2019s bases as fenamate isosteres","volume":"25","author":"Alafeefy","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ccr.2017.11.030","article-title":"Multidentate unsymmetrically-substituted Schiff bases and their metal complexes: synthesis, functional materials properties, and applications to catalysis","volume":"357","author":"Liu","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejmech.2016.05.015","article-title":"Aroylhydrazone iron chelators: tuning antioxidant and antiproliferative properties by hydrazide modifications","volume":"120","author":"Hru\u0161kov\u00e1","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0260","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1158\/1078-0432.CCR-04-0865","article-title":"Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves Fenton-derived free radical generation","volume":"10","author":"Chaston","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jinorgbio.2010.03.018","article-title":"Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium (V) and its permeability and cytotoxicity","volume":"104","author":"Xie","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0270","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1039\/c2dt11514j","article-title":"Highly cytotoxic vanadium (V) complexes of salan ligands; insights on the role of hydrolysis","volume":"41","author":"Reytman","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2017.04.053","article-title":"Self-recognition of the racemic ligand in the formation of homochiral dinuclear V (V) complex: in vitro anticancer activity, DNA and HSA interaction","volume":"135","author":"Kazemi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0280","doi-asserted-by":"crossref","first-page":"119276","DOI":"10.1016\/j.ica.2019.119276","article-title":"Di-\u03bc-oxidovanadium (V) di-nuclear complexes: synthesis, X-ray, DFT modeling, Hirshfeld surface analysis and antioxidant activity","volume":"501","author":"Hasnaoui","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0285","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/inorganics9090066","article-title":"Study of DNA interaction and cytotoxicity activity of oxidovanadium (V) complexes with ONO donor Schiff base ligands","volume":"9","author":"Sahu","year":"2021","journal-title":"Inorganics"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.poly.2019.06.051","article-title":"Synthesis, structure, and cytotoxicity studies of oxidovanadium (IV and V) complexes bearing chelating phenolates","volume":"171","author":"Miller-Shakesby","year":"2019","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0295","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.ejmech.2010.10.013","article-title":"Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity","volume":"45","author":"Xie","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0300","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1021\/acsomega.0c00360","article-title":"New palladium (II) and platinum (II) complexes based on pyrrole schiff bases: synthesis, characterization, X-ray structure, and anticancer activity","volume":"5","author":"Mbugua","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0305","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1039\/C9CC09312E","article-title":"Photoactive metal complexes that bind dna and other biomolecules as cell probes, therapeutics, and theranostics","volume":"56","author":"Saeed","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0310","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1002\/anie.201001040","article-title":"X-ray structures of copper(II) and nickel(II) radical salen complexes: the preference of galactose oxidase for copper(II)","volume":"49","author":"Orio","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0315","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1039\/b105186p","article-title":"A phenoxyl radical complex of copper","author":"Benisvy","year":"2001","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0320","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1021\/ic2016676","article-title":"Nuclease activity via self-activation and anticancer activity of a mononuclear copper(II) complex: novel role of the tertiary butyl group in the ligand frame","volume":"51","author":"Ghosh","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0325","doi-asserted-by":"crossref","first-page":"118993","DOI":"10.1016\/j.ica.2019.118993","article-title":"The influence of the tertiary butyl group in the ligand frame on the catalytic activities, DNA cleavage ability and cytotoxicity of dinuclear nickel (II) complexes","volume":"495","author":"Kumar","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0330","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinorgbio.2015.02.021","article-title":"Vanadium (IV) and copper (II) complexes of salicylaldimines and aromatic heterocycles: cytotoxicity, DNA binding and DNA cleavage properties","volume":"147","author":"Correia","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0335","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/cr9601324","article-title":"Self-assembly of discrete cyclic nanostructures mediated by transition metals","volume":"100","author":"Leininger","year":"2000","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/ar0000105","article-title":"New materials in hydrothermal synthesis","volume":"34","author":"Feng","year":"2001","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0350","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0355","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1021\/ic401197a","article-title":"Anticancer activity and DNA binding of a bifunctional Ru (II) arene aqua-complex with the 2, 4-diamino-6-(2-pyridyl)-1, 3, 5-triazine ligand","volume":"52","author":"Busto","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0360","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1021\/ja981937r","article-title":"Sequence selective cleavage of a DNA octanucleotide by chlorinated bithiazoles and bleomycins","volume":"120","author":"Zuber","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2007.03.022","article-title":"Synthesis, characterization and biological activity of Schiff base analogues of indole-3-carboxaldehyde","volume":"43","author":"Sinha","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0370","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1039\/C5DT00931F","article-title":"Synthesis, characterization, DNA\/BSA interactions and anticancer activity of achiral and chiral copper complexes","volume":"44","author":"Zhou","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0375","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0167-4838(01)00287-4","article-title":"Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modelling","volume":"1594","author":"Gelamo","year":"2002","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0380","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1039\/C7NJ00887B","article-title":"Synthesis, structures, DNA\/protein binding, molecular docking, anticancer activity and ROS generation of Ni (II), Cu (II) and Zn (II) 5, 5-diethylbarbiturate complexes with bis (2-pyridylmethyl) amine and terpyridine","volume":"41","author":"Yilmaz","year":"2017","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0385","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1039\/c0dt01657h","article-title":"Effect of terminal N-substitution in 2-oxo-1, 2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the mode of coordination, structure, interaction with protein, radical scavenging and cytotoxic activity of copper (II) complexes","volume":"40","author":"Raja","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0390","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1021\/ic401662d","article-title":"DNA\/protein binding, molecular docking, and in vitro anticancer activity of some thioether-dipyrrinato complexes","volume":"52","author":"Gupta","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0395","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.1021\/acs.inorgchem.9b02696","article-title":"Cycloplatinated (II) derivatives of mercaptopurine capable of binding interactions with HSA\/DNA","volume":"58","author":"Aseman","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0400","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1039\/C9DT04656A","article-title":"Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu (II)\/Zn (II) complexes containing a carbohydrazone ligand","volume":"49","author":"Parsekar","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0405","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejmech.2012.08.001","article-title":"Organometallic ruthenium (II) complexes: synthesis, structure and influence of substitution at azomethine carbon towards DNA\/BSA binding, radical scavenging and cytotoxicity","volume":"55","author":"Sathyadevi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0410","doi-asserted-by":"crossref","first-page":"12564","DOI":"10.1021\/acs.inorgchem.0c01663","article-title":"Effect of the heteroaromatic antenna on the binding of chiral Eu (III) complexes to bovine serum albumin","volume":"59","author":"de Rosa","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0415","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1021\/acs.inorgchem.0c00742","article-title":"Alkyne functionalization of a photoactivated ruthenium polypyridyl complex for click-enabled serum albumin interaction studies","volume":"59","author":"Busemann","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0420","doi-asserted-by":"crossref","first-page":"16276","DOI":"10.1039\/C7DT03585C","article-title":"Exploring the effect of substituent in the hydrazone ligand of a family of \u03bc-oxidodivanadium (v) hydrazone complexes on structure, DNA binding and anticancer activity","volume":"46","author":"Patra","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0425","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jinorgbio.2012.02.034","article-title":"Synthesis and characterization of unsymmetrical oxidovanadium complexes: DNA-binding, cleavage studies and antitumor activities","volume":"112","author":"Lu","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0430","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1039\/c4dt00883a","article-title":"Syntheses and structural investigation of some alkali metal ion-mediated LV(V)O2(\u2212) (L(2-) = tridentate ONO ligands) species: DNA binding, photo-induced DNA cleavage and cytotoxic activities","volume":"43","author":"Dash","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2014.12.018","article-title":"Evaluation of the cell cytotoxicity and DNA\/BSA binding and cleavage activity of some dioxidovanadium(V) complexes containing aroylhydrazones","volume":"144","author":"Dash","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0440","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.1021\/acs.inorgchem.0c01837","article-title":"New VIV, VIVO, VVO, and VVO2 systems: exploring their interconversion in solution, protein interactions, and cytotoxicity","volume":"59","author":"Banerjee","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0445","doi-asserted-by":"crossref","first-page":"110786","DOI":"10.1016\/j.jinorgbio.2019.110786","article-title":"Chemistry of mixed-ligand oxidovanadium (IV) complexes of aroylhydrazones incorporating quinoline derivatives: study of solution behavior, theoretical evaluation and protein\/DNA interaction","volume":"199","author":"Banerjee","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0450","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1039\/D0NJ01246G","article-title":"Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium (iv) complexes: DNA\/HSA interaction, cytotoxic activity and DFT studies","volume":"44","author":"Banerjee","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0455","doi-asserted-by":"crossref","first-page":"18292","DOI":"10.1039\/C6DT03228A","article-title":"A study of DNA\/BSA interaction and catalytic potential of oxidovanadium(v) complexes with ONO donor ligands","volume":"45","author":"Dash","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0460","doi-asserted-by":"crossref","first-page":"51852","DOI":"10.1039\/C4RA14369H","article-title":"Oxidovanadium(v) complexes of aroylhydrazones incorporating heterocycles: synthesis, characterization and study of DNA binding, photo-induced DNA cleavage and cytotoxic activities","volume":"5","author":"Dash","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0465","doi-asserted-by":"crossref","first-page":"14096","DOI":"10.1021\/ic401866x","article-title":"Highly stable hexacoordinated nonoxidovanadium(IV) complexes of sterically constrained ligands: syntheses, structure, and study of antiproliferative and insulin mimetic activity","volume":"52","author":"Dash","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0470","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.poly.2011.10.017","article-title":"Oxovanadium(V) complexes incorporating tridentate aroylhydrazoneoximes: Synthesis, characterizations and antibacterial activity","volume":"31","author":"Dash","year":"2012","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0475","doi-asserted-by":"crossref","first-page":"114533","DOI":"10.1016\/j.poly.2020.114533","article-title":"Investigation of DNA interaction and antiproliferative activity of mixed ligand dioxidomolybdenum (VI) complexes incorporating ONO donor aroylhydrazone ligands","volume":"183","author":"Dinda","year":"2020","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0480","doi-asserted-by":"crossref","first-page":"17711","DOI":"10.1039\/C9NJ01910C","article-title":"Synthesis, structure and biological evaluation of mixed ligand oxidovanadium (IV) complexes incorporating 2-(arylazo) phenolates","volume":"43","author":"Lima","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0485","doi-asserted-by":"crossref","first-page":"11190","DOI":"10.1021\/acs.inorgchem.7b01578","article-title":"Monomeric and dimeric oxidomolybdenum(V and VI) complexes, cytotoxicity, and DNA interaction studies: molybdenum assisted CN bond cleavage of salophen ligands","volume":"56","author":"Majumder","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0490","doi-asserted-by":"crossref","first-page":"110908","DOI":"10.1016\/j.jinorgbio.2019.110908","article-title":"Polynuclear zinc (II) complexes of thiosemicarbazone: synthesis, X-ray structure and biological evaluation","volume":"203","author":"Mohanty","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0495","doi-asserted-by":"crossref","first-page":"17680","DOI":"10.1039\/C9NJ01815H","article-title":"In vitro cytotoxicity and catalytic evaluation of dioxidovanadium (v) complexes in an azohydrazone ligand environment","volume":"43","author":"Mohanty","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0500","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.poly.2014.04.007","article-title":"Synthesis, structure, characterization and study of antiproliferative activity of dimeric and tetrameric oxidomolybdenum(VI) complexes of N,N\u2032-disalicyloylhydrazine","volume":"80","author":"Pasayat","year":"2014","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0505","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.poly.2012.03.007","article-title":"Mixed-ligand aroylhydrazone complexes of molybdenum: Synthesis, structure and biological activity","volume":"38","author":"Pasayat","year":"2012","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0510","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1021\/acs.inorgchem.8b00035","article-title":"Anionic dinuclear oxidovanadium(IV) complexes with azo functionalized tridentate ligands and \u03bc-Ethoxido bridge leading to an unsymmetric twisted arrangement: synthesis, X-ray structure, magnetic properties, and cytotoxicity","volume":"57","author":"Roy","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0515","doi-asserted-by":"crossref","first-page":"15526","DOI":"10.1021\/acs.inorgchem.0c02563","article-title":"Probing CO generation through metal-assisted alcohol dehydrogenation in Metal-2-(arylazo) phenol complexes using isotopic labeling (metal= Ru, Ir): synthesis, characterization, and cytotoxicity studies","volume":"59","author":"Roy","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0520","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jinorgbio.2017.04.015","article-title":"Synthesis, structure and cytotoxicity of a series of Dioxidomolybdenum(VI) complexes featuring Salan ligands","volume":"172","author":"Roy","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0525","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1021\/acs.inorgchem.1c01899","article-title":"Water-soluble dioxidovanadium (V) complexes of aroylhydrazones: DNA\/BSA interactions, hydrophobicity, and cell-selective anticancer potential","volume":"60","author":"Sahu","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0530","doi-asserted-by":"crossref","first-page":"11358","DOI":"10.1039\/C8DT01668B","article-title":"Synthesis, structure, solution behavior, reactivity and biological evaluation of oxidovanadium(iv\/v) thiosemicarbazone complexes","volume":"47","author":"Saswati","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0535","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1039\/C4DT03764B","article-title":"Synthesis, X-ray structure and in vitro cytotoxicity studies of Cu(I\/II) complexes of thiosemicarbazone: special emphasis on their interactions with DNA","volume":"44","author":"Saswati","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0540","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.poly.2012.11.031","article-title":"Mixed-ligand nickel(II) thiosemicarbazone complexes: synthesis, characterization and biological evaluation","volume":"50","author":"Saswati","year":"2013","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0545","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/9780470132364.ch30","article-title":"Vanadium (IV) oxy (acetylacetonate)","volume":"5","author":"Bryant","year":"1957","journal-title":"Inorg. Synth."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0550","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1021\/jm00157a020","article-title":"Esters and lactones of phenolic amino carboxylic acids. Prodrugs for iron chelation","volume":"29","author":"Pitt","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0555","series-title":"Collect: Data Collection Software, ed, BV Nonius, Delft, The Netherlands","author":"Hooft","year":"1998"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0560","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"[20] Processing of X-ray diffraction data collected in oscillation mode","author":"Otwinowski","year":"1997"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0565","series-title":"Madison, WI, U.S.A","author":"SADABS 2.10, Bruker-AXS inc","year":"2002"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0570","series-title":"APEX3 Bruker AXS LLC, Madison, WI, USA","volume":"2020","author":"6. Bruker","year":"2020"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"Crystal structure solution with ShelXT","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0585","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1107\/S2053229614024929","article-title":"PLATON SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors","volume":"71","author":"Spek","year":"2015","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0590","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/ic2017177","article-title":"Mixed ligand copper (II) complexes of N, N-bis (benzimidazol-2-ylmethyl) amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity","volume":"51","author":"Loganathan","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0595","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1039\/C3DT51641E","article-title":"New ruthenium (II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity","volume":"43","author":"Ganeshpandian","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0600","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejmech.2017.09.007","article-title":"Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium (II) \u03b2-carboline complexes","volume":"140","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0605","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1039\/D0DT01017K","article-title":"In vitro antiproliferative effect of vanadium complexes bearing 8-hydroxyquinoline-based ligands\u2013the substituent effect","volume":"49","author":"Choroba","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0610","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1021\/acs.inorgchem.7b02684","article-title":"High catalytic activity of vanadium complexes in alkane oxidations with hydrogen peroxide: An effect of 8-hydroxyquinoline derivatives as noninnocent ligands","volume":"57","author":"Gryca","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0615","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/acs.inorgchem.6b01001","article-title":"Versatile reactivity and theoretical evaluation of mono- and dinuclear oxidovanadium(V) compounds of aroylazines: electrogeneration of mixed-valence divanadium(IV,V) complexes","volume":"55","author":"Dash","year":"2016","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0620","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/acs.inorgchem.5b02346","article-title":"Chemistry of monomeric and dinuclear non-oxido vanadium(IV) and oxidovanadium(V) aroylazine complexes: exploring solution behavior","volume":"55","author":"Dash","year":"2016","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0625","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/zaac.19946200924","article-title":"Structural and spectroscopic characterization of six-coordinate vanadium(V) complexes: a structural model for the active site of vanadium-dependent haloperoxidases","volume":"620","author":"Plass","year":"1994","journal-title":"Z. Anorg. Allg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0630","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.1021\/acs.inorgchem.0c01837","article-title":"New VIV, VIVO, VVO, and VVO2 systems: exploring their interconversion in solution, protein interactions, and cytotoxicity","volume":"59","author":"Banerjee","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0635","doi-asserted-by":"crossref","first-page":"111582","DOI":"10.1016\/j.jinorgbio.2021.111582","article-title":"Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium (V) salan complexes: exploring the solution behavior of monoalkoxido-bound oxido-vanadium (V) complex","volume":"224","author":"Patra","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0640","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1021\/ic702172p","article-title":"Solution study of a structurally characterized monoalkoxo-bound monooxo-vanadium(V) complex: spontaneous generation of the corresponding oxobridged divanadium(V,V) complex and its electroreduction to a mixed-valence species in solution","volume":"47","author":"Dinda","year":"2008","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0645","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ica.2010.09.021","article-title":"Oxo-bridged bis oxo-vanadium (V) complexes with tridentate Schiff base ligands (VOL) 2O (L= SAE, SAMP, SAP): synthesis, structure and epoxidation catalysis under solvent-free conditions","volume":"364","author":"Cordelle","year":"2010","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0650","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1021\/ic010865t","article-title":"Valence delocalization in a mixed-oxidation divanadium (IV, V) complex electrogenerated from its structurally characterized divanadium (V) analogue with a tridentate (ONO) ligand","volume":"41","author":"Dinda","year":"2002","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0655","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ica.2010.09.021","article-title":"Oxo-bridged bis oxo-vanadium(V) complexes with tridentate Schiff base ligands (VOL)2O (L=SAE, SAMP, SAP): synthesis, structure and epoxidation catalysis under solvent-free conditions","volume":"364","author":"Cordelle","year":"2010","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0660","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/ejic.200800063","article-title":"Mixed-ligand Oxidovanadium(V) complexes with N\u2032 -Salicylidenehydrazides: synthesis, structure, and 51 V solid-state MAS NMR investigation","author":"Nica","year":"2008","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0665","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/zaac.19976230174","article-title":"Vanadium(V) complexes with flexible and hydrolytically stable amine alcohol ligands and their isomerization in solution: models for the interaction of vanadium(V) with biogenic ligands","volume":"623","author":"Plass","year":"1997","journal-title":"Z. Anorg. Allg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0670","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1515\/znb-1993-1227","article-title":"Crystal structure of \u03bc-Oxo-bis[oxo-salicylaldehydbenzoylhydrazonato(2\u2013)]vanadium(V)","volume":"48","author":"Sundheim","year":"1993","journal-title":"Z. Naturforsch. B"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0675","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/ejic.201501465","article-title":"Synthesis, theoretical study and catalytic application of oxidometal (Mo or V) complexes: unexpected coordination due to ligand rearrangement through metal-mediated C-C bond formation","volume":"2016","author":"Pasayat","year":"2016","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0680","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jinorgbio.2015.02.009","article-title":"Vanadium(V) complex with Schiff-base ligand containing a flexible amino side chain: synthesis, structure and reactivity","volume":"147","author":"Nica","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0685","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.copbio.2007.09.006","article-title":"DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action","volume":"18","author":"Palchaudhuri","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0690","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature12743","article-title":"The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition","volume":"503","author":"Bloodgood","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0695","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejmech.2014.05.075","article-title":"Biological evaluation of new nickel (II) metallates: synthesis, DNA\/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool","volume":"82","author":"Kalaivani","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0700","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jphotobiol.2016.09.005","article-title":"Cu (II), Ni (II) complexes derived from chiral Schiff-base ligands: Synthesis, characterization, cytotoxicity, protein and DNA\u2013binding properties","volume":"163","author":"Li","year":"2016","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0705","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1039\/B516132K","article-title":"Double-strand DNA cleavage by copper complexes of 2, 2\u2032-dipyridyl with electropositive pendants","author":"An","year":"2006","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0710","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1039\/b206079p","article-title":"Interaction of macrocyclic copper (II) complexes with calf thymus DNA: effects of the side chains of the ligands on the DNA-binding behaviors","author":"Liu","year":"2003","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0715","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1021\/ja003985t","article-title":"Synthesis of [Ru (phen) 2dppz] 2+\u2212tethered oligo-DNA and studies on the metallointercalation mode into the DNA duplex","volume":"123","author":"Ossipov","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0720","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/ic700755p","article-title":"Mixed-ligand copper (II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity","volume":"46","author":"Rajendiran","year":"2007","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0725","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1016\/j.ejmech.2011.07.038","article-title":"Biological evaluation of a novel water soluble Sulphur bridged binuclear copper (II) thiosemicarbazone complex","volume":"46","author":"Raja","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0730","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1039\/C6NJ03516G","article-title":"New binuclear Ni (II) metallates containing ONS chelators: synthesis, characterisation, DNA binding, DNA cleavage, protein binding, antioxidant activity, antimicrobial and in vitro cytotoxicity","volume":"41","author":"Kalaiarasi","year":"2017","journal-title":"New J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0735","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejmech.2016.02.055","article-title":"Copper complexes based on chiral Schiff-base ligands: DNA\/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis","volume":"114","author":"Zhou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0740","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1021\/bi00798a001","article-title":"Differences between bovine and human serum albumins. Binding isotherms, optical rotatory dispersion, viscosity, hydrogen ion titration, and fluorescence effects","volume":"10","author":"Steinhardt","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0745","doi-asserted-by":"crossref","first-page":"14175","DOI":"10.1021\/acs.inorgchem.9b02227","article-title":"Ferrocene-appended iridium (III) complexes: configuration regulation, anticancer application, and mechanism research","volume":"58","author":"Ge","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0750","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1039\/c2dt31306e","article-title":"Synthesis, characterization, DNA binding and cleavage, BSA interaction and anticancer activity of dinuclear zinc complexes","volume":"41","author":"Gao","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0755","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0010-8545(03)00050-X","article-title":"Multi-nuclear platinum complexes as anti-cancer drugs","volume":"241","author":"Wheate","year":"2003","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0760","first-page":"809","article-title":"Metal complexes as drugs and chemotherapeutic agents","volume":"9","author":"Farrell","year":"2003","journal-title":"Compr. Coord. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0765","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/bi00493a005","article-title":"A comparison of chemical reactivity, cytotoxicity, interstrand crosslinking and DNA sequence specificity of bis (platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogs","volume":"29","author":"Farrell","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0770","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14499\/indonesianjcanchemoprev11iss1pp16-21","article-title":"Synergistic cytotoxicity effect by combination of methanol extract of Parijoto fruit (Medinilla speciosa Reinw. ex. Bl) and cisplatin against HeLa cell line","volume":"11","author":"Artanti","year":"2020","journal-title":"Indones. J. Cancer Chemoprevention"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0775","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1039\/C5DT04374C","article-title":"New Fe (III) and Co (II) salen complexes with pendant distamycins: selective targeting of cancer cells by DNA damage and mitochondrial pathways","volume":"45","author":"Ali","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0780","doi-asserted-by":"crossref","first-page":"111390","DOI":"10.1016\/j.jinorgbio.2021.111390","article-title":"The first copper (I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy","volume":"218","author":"Liu","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0785","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinorgbio.2019.01.009","article-title":"Syntheses, crystal structures and biological evaluation of two new Cu (II) and Co (II) complexes based on (E)-2-(((4H-1, 2, 4-triazol-4-yl) imino) methyl)-6-methoxyphenol","volume":"193","author":"Zhang","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0790","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ejmech.2018.09.034","article-title":"Piperidylthiosemicarbazones Cu (II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis","volume":"158","author":"Qi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0795","doi-asserted-by":"crossref","first-page":"17109","DOI":"10.1021\/acs.inorgchem.0c02373","article-title":"Synthesis of palladium (II) complexes via Michael addition: antiproliferative effects through ROS-mediated mitochondrial apoptosis and docking with SARS-CoV-2","volume":"59","author":"Haribabu","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0800","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1021\/jm101096x","article-title":"Preparation and characterization of amino-linked heterocyclic carbene palladium, gold, and silver complexes and their use as anticancer agents that act by triggering apoptotic cell death","volume":"54","author":"Wang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0805","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jinorgbio.2016.11.008","article-title":"G2\/M cell cycle arrest on HT-29 cancer cells and toxicity assessment of triphenylphosphanegold (I) carbonimidothioates, Ph3PAu [SC (OR)= NPh], R= Me, Et, and iPr, during zebrafish development","volume":"166","author":"Ooi","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0810","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1039\/C8QI00920A","article-title":"Dual-functional cyclometalated iridium imine NHC complexes: highly potent anticancer and antimetastatic agents","volume":"5","author":"Tian","year":"2018","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0815","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat.Protoc."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0820","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1021\/acs.inorgchem.0c00319","article-title":"Selective coordination mode of acylthiourea ligands in half-sandwich Ru (II) complexes and their cytotoxic evaluation","volume":"59","author":"Cunha","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0825","doi-asserted-by":"crossref","first-page":"41118","DOI":"10.1021\/acsami.8b14940","article-title":"Disulfiram copper nanoparticles prepared with a stabilized metal ion ligand complex method for treating drug-resistant prostate cancers","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jinorgbio.2022.111852_bb0830","doi-asserted-by":"crossref","first-page":"12865","DOI":"10.1039\/C7DT01801K","article-title":"Half sandwich Ru (II)-acylthiourea complexes: DNA\/HSA-binding, anti-migration and cell death in a human breast tumor cell line","volume":"46","author":"Colina-Vegas","year":"2017","journal-title":"Dalton Trans."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:06:24Z","timestamp":1758985584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013422001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":166,"alternative-id":["S0162013422001416"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111852","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of DNA\/BSA interaction and in vitro cell cytotoxicity of \u03bc2-oxido bridged divanadium(V) complexes containing ONO donor ligands","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111852"}}